Skip to main content
SpringerLink
Log in

Hematopoietic Growth Factors

  • Chapter
Hematologic Malignancies: Myelodysplastic Syndromes

Part of the book series: Hematologic Malignancies ((HEMATOLOGIC))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Asano H, Ohashi H, Ichihara M, Kinoshita T, Murate T, Kobayashi M, Saito H, Hotta T (1994) Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. Blood 84:588–594

    PubMed  CAS  Google Scholar 

  • Backx B, Broeders L, Lowenberg B (1992) Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome. Blood 80:1213–1217

    PubMed  CAS  Google Scholar 

  • Backx B, Broeders L, Touw I, Lowenberg B (1993) Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors. Leukemia 7:75–79

    PubMed  CAS  Google Scholar 

  • Bennett JM (2000) World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematol 72:131–133

    PubMed  CAS  Google Scholar 

  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C, The French-American-British (FAB) Co-Operative Group (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189–199

    PubMed  CAS  Google Scholar 

  • Boudard D, Sordet O, Piselli S, Viallet A, Guyotat D, Campos L (2002) Increased caspase-3 activity in refractory anemias: lack of evidence for Fas pathway implication. Leukemia 16:2343–2345

    Article  PubMed  CAS  Google Scholar 

  • Casadevall N, Durieux P, Dubois S, Hemery F, Lepage E, Quarre MC, Damaj G, Giraudier S, Guerci A, Laurent G, Dombret H, Chomienne C, Ribrag V, Stamatoullas A, Marie JP, Vekhoff A, Maloisel F, Navarro R, Dreyfus F, Fenaux P (2004) Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial. Blood 104:321–327

    Article  PubMed  CAS  Google Scholar 

  • Cazzola M, Barosi G, Berzuini C, Dacco M, Orlandi E, Stefanelli M, Ascari E (1982) Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol 50:55–62

    PubMed  CAS  Google Scholar 

  • Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, Rolandi V, Biasiotto G, Drysdale J, Arosio P (2003) Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 101:1996–2000

    Article  PubMed  CAS  Google Scholar 

  • Chalevelakis G, Karaoulis S, Yalouris AG, Economopoulos T, Tountas N, Raptis S (1991) Globin chain synthesis in myelodysplastic syndromes. J Clin Pathol 44:134–138

    PubMed  CAS  Google Scholar 

  • Claessens YE, Bouscary D, Dupont JM, Picard F, Melle J, Gisselbrecht S, Lacombe C, Dreyfus F, Mayeux P, Fontenay-Roupie M (2002) In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis. Blood 99:1594–1601

    Article  PubMed  CAS  Google Scholar 

  • Di Raimondo F, Longo G, Cacciola E Jr, Milone G, Palumbo GA, Cacciola RR, Alessi M, Giustolisi R (1996) A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study. Eur J Haematol 56:7–11

    PubMed  Google Scholar 

  • Dror Y (2003) The role of mitochondrial-mediated apoptosis in a myelodysplastic syndrome secondary to congenital deletion of the short arm of chromosome 4. Exp Hematol 31:211–217

    Article  PubMed  CAS  Google Scholar 

  • Economopoulos T, Mellou S, Papageorgiou E, Pappa V, Kokkinou V, Stathopoulou E, Pappa M, Raptis S (1999) Treatment of anemia in low risk myelodysplastic syndromes with granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin. Leukemia 13:1009–1012

    PubMed  CAS  Google Scholar 

  • Garypidou V, Verrou E, Vakalopoulou S, Perifanis V, Tziomalos K, Venizelos I (2003) Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes. Br J Haematol 123:958

    Article  PubMed  Google Scholar 

  • Gattermann N (2004) Mitochondrial DNA mutations in the hematopoietic system. Leukemia 18:18–22

    Article  PubMed  CAS  Google Scholar 

  • Gattermann N, Wulfert M, Junge B, Germing U, Haas R, Hofhaus G (2004) Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome. Blood 103:1499–1502

    PubMed  CAS  Google Scholar 

  • Germing U, Gattermann N, Aivado M, Hildebrandt B, Aul C (2000a) Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction. Br J Haematol 108:724–728

    Article  PubMed  CAS  Google Scholar 

  • Germing U, Gattermann N, Strupp C, Aivado M, Aul C (2000 b) Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res 24:983–992

    Article  PubMed  CAS  Google Scholar 

  • Giagounidis AA, Germing U, Haase S, Hildebrandt B, Schlegelberger B, Schoch C, Wilkens L, Heinsch M, Willems H, Aivado M, Aul C (2004) Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31. Leukemia 18:113–119

    Article  PubMed  CAS  Google Scholar 

  • Hansen PB, Johnsen HE, Hippe E, Hellstrom-Lindberg E, Ralfkiaer E (1993) Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes. Am J Hematol 44:229–236

    PubMed  CAS  Google Scholar 

  • Hast R, Wallvik J, Folin A, Bernell P, Stenke L (2001) Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment. Leuk Res 25:13–18

    Article  PubMed  CAS  Google Scholar 

  • Hellstrom-Lindberg E (1995) Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. Br J Haematol 89:67–71

    PubMed  CAS  Google Scholar 

  • Hellstrom-Lindberg E, Birgegard G, Carlsson M, Cameskog J, Dahl IM, Dybedal I, Grimfors G, Merk K, Tangen JM, Winqvist I (1993) A combination of granulocyte colony-stimulating factor and erythropoietin may synergistically improve the anaemia in patients with myelodysplastic syndromes. Leuk Lymphoma 11:221–228

    Article  PubMed  CAS  Google Scholar 

  • Hellstrom-Lindberg E, Kanter-Lewensohn L, Ost A (1997 a) Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. Leuk Res 21:415–425

    PubMed  CAS  Google Scholar 

  • Hellstrom-Lindberg E, Negrin R, Stein R, Krantz S, Lindberg G, Vardiman J, Ost A, Greenberg P (1997b) Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br J Haematol 99:344–351

    Article  PubMed  CAS  Google Scholar 

  • Hellstrom-Lindberg E, Ahlgren T, Beguin Y, Carlsson M, Cameskog J, Dahl IM, Dybedal I, Grimfors G, Kanter-Lewensohn L, Linder O, Luthman M, Lofvenberg E, Nilsson-Ehle H, Samuelsson J, Tangen JM, Winqvist I, Oberg G, Osterborg A, Ost A (1998) Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood 92:68–75

    PubMed  CAS  Google Scholar 

  • Hellstrom-Lindberg E, Schmidt-Mende J, Forsblom AM, Christensson B, Fadeel B, Zhivotovsky B (2001) Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases. Br J Haematol 112:714–726

    PubMed  CAS  Google Scholar 

  • Hellstrom-Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl IM, Dybedal I, Grimfors G, Hesse-Sundin E, Hjorth M, Kanter-Lewensohn L, Linder O, Luthman M, Lofvenberg E, Oberg G, Porwit-Mac-Donald A, Radlund A, Samuelsson J, Tangen JM, Winquist I, Wisloff F, Scandinavian MDS (2003) A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life. Br J Haematol 120:1037–1046

    Article  PubMed  CAS  Google Scholar 

  • Higgs DR, Wood WG, Barton C, Weatherall DJ (1983) Clinical features and molecular analysis of acquired hemoglobin H disease. Am J Med 75:181–191

    Article  PubMed  CAS  Google Scholar 

  • Howe RB, Porwit-MacDonald A, Wanat R, Tehranchi R, Hellstrom-Lindberg E (2004) The WHO classification of MDS does make a difference. Blood 103:3265–3270

    Article  PubMed  CAS  Google Scholar 

  • Imamura M, Kobayashi M, Kobayashi S, Yoshida K, Mikuni C, Ishikawa Y, Matsumoto S, Sakamaki S, Niitsu Y, Hinoda Y (1994) Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodysplastic syndromes. Ann Hematol 68:163–166

    Article  PubMed  CAS  Google Scholar 

  • Italian Cooperative Study Group for rHuEpo in Myelodysplastic Syndromes (1998) A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Br J Haematol 103:1070–1074

    Google Scholar 

  • Koeffler HP, Cline MJ, Golde DW (1978) Erythropoiesis in preleukemia. Blood 51:1013–1019

    PubMed  CAS  Google Scholar 

  • Lepelley P, Campergue L, Grardel N, Preudhomme C, Cosson A, Fenaux P (1996) Is apoptosis a massive process in myelodysplastic syndromes? Br J Haematol 95:368–371

    Article  PubMed  CAS  Google Scholar 

  • Lintula R (1986) Red cell enzymes in myelodysplastic syndromes: a review. Scand J Haematol Suppl 45:56–59

    PubMed  CAS  Google Scholar 

  • List AF, Brasfield F, Heaton R, Glinsmann-Gibson B, Crook L, Taetle R, Capizzi R (1997) Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome. Blood 90:3364–3369

    PubMed  CAS  Google Scholar 

  • Mantovani L, Lentini G, Hentschel B, Wickramanayake PD, Loeffler M, Diehl V, Tesch H (2000) Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin. Br J Haematol 109:367–375

    Article  PubMed  CAS  Google Scholar 

  • Matthes TW, Meyer G, Samii K, Beris P (2000) Increased apoptosis in acquired sideroblastic anaemia. Br J Haematol 111:843–852

    Article  PubMed  CAS  Google Scholar 

  • May SJ, Smith SA, Jacobs A, Williams A, Bailey-Wood R (1985) The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classification. Br J Haematol 59:311–319

    PubMed  CAS  Google Scholar 

  • Michalopoulou S, Micheva I, Kouraklis-Symeonidis A, Kakagianni T, Symeonidis A, Zoumbos NC (2004) Impaired clonogenic growth of myelodysplastic bone marrow progenitors in vitro is irrelevant to their apoptotic state. Leuk Res 28:805–812

    Article  PubMed  Google Scholar 

  • Negrin RS, Nagler A, Kobayashi Y, et al (1992) Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony stimulating factor. Blood 78:36–43

    Google Scholar 

  • Negrin RS, Stein R, Vardiman J, Doherty K, Cornwell J, Krantz S, Greenberg PL (1993) Treatment of the anemia of myelodysplatic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood 82:737–743

    PubMed  CAS  Google Scholar 

  • Negrin RS, Stein R, Doherty K, Cornwell J, Vardiman J, Krantz S, Greenberg PL (1996) Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy. Blood 87:4076–4081

    PubMed  CAS  Google Scholar 

  • Nilsson L, Astrand-Grundstrom I, Arvidsson I, Jacobsson B, Hellstrom-Lindberg E, Hast R, Jacobsen SE (2000) Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood 96:2012–2021

    PubMed  CAS  Google Scholar 

  • Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A (2000) The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood 96:3932–3938

    PubMed  CAS  Google Scholar 

  • Peddie CM, Wolf CR, McLellan LI, Collins AR, Bowen DT (1997) Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor-alpha concentration. Br J Haematol 99:625–631

    Article  PubMed  CAS  Google Scholar 

  • Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A, Loew J, Marcus B, Khan Z, Chaney C, Showel J, Gregory S, Preisler H (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 86:268–276

    PubMed  CAS  Google Scholar 

  • Raza A, Mundle S, Shetty V, Alvi S, Chopra H, Span L, Parcharidou A, Dar S, Venugopal P, Borok R, Gezer S, Showel J, Loew J, Robin E, Rifkin S, Alston D, Hernandez B, Shah R, Kaizer H, Gregory S, Preisler H (1996) A paradigm shift in myelodysplastic syndromes. Leukemia 10:1648–1652

    PubMed  CAS  Google Scholar 

  • Remacha AF, Arrizabalaga B, Villegas A, Manteiga R, Calvo T, Julia A, Fernandez F, I, Gonzalez FA, Font L, Junca J, del Arco A, Malcorra JJ, Equiza EP, de Mendiguren BP, Romero M (1999) Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. Haematologica 84:1058–1064

    PubMed  CAS  Google Scholar 

  • Rigolin GM, Porta MD, Bigoni R, Cavazzini F, Ciccone M, Bardi A, Cuneo A, Castoldi G (2002) rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors’ response by fluorescence in situ hybridization on May-Grun-wald-Giemsa-stained bone marrow samples. Br J Haematol 119:652–659

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez JN, Dieguez JC, Muniz R, Martino ML, Femandez-Jurado A, Amian A, Canavate M, Prados D (1994) Human recombinant erythropoietin in the treatment of myelodysplastic syndromes anemia: meta-analytic study [Spanish]. Sangre 39:435–439

    PubMed  CAS  Google Scholar 

  • Rose EH, Abels Rl, Nelson RA, McCullough DM, Lessin L (1995) The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS). Br J Haematol 89:831–837

    PubMed  CAS  Google Scholar 

  • Sanz GF, Sanz MA, Vallespì T, Cañizo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 74:395–408

    PubMed  CAS  Google Scholar 

  • Sawada K, Sato N, Notoya A, Tarumi T, Hirayama S, Takano H, Koizumi K, Yasukouchi T, Yamaguchi M, Koike T (1995) Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopu-lations of marrow CD34+ cells. Blood 85:194–202

    PubMed  CAS  Google Scholar 

  • Schmidt-Mende J, Tehranchi R, Forsblom AM, Joseph B, Christensson B, Fadeel B, Zhivotovsky B, Hellstrom-Lindberg E (2001) Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts. Leukemia 15:742–751

    Article  PubMed  CAS  Google Scholar 

  • Shin MG, Kajigaya S, Levin BC, Young NS (2003) Mitochondrial DNA mutations in patients with myelodysplastic syndromes. Blood 101:3118–3125

    Article  PubMed  CAS  Google Scholar 

  • Sokol RJ, Hewitt S, Booker DJ (1989) Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes. J Clin Pathol 42:1088–1091

    PubMed  CAS  Google Scholar 

  • Stasi R, Brunetti M, Bussa S, Conforti M, Di Giulio C, Crescenzi A, Terzoli E, Vecchione A, Pagano A (1997a)

    Google Scholar 

  • Response to recombinant human erythropoietin in patients with myelodysplastic syndromes. Clin Cancer Res 3:733–739

    Google Scholar 

  • Stasi R, Brunetti M, Bussa S, Conforti M, Martin LS, La Presa M, Bianchi M, Parma A, Pagano A (1997 b) Serum levels of tumour necrosis factor-alpha predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome. Clin Lab Haematol 19:197–201

    Article  PubMed  CAS  Google Scholar 

  • Stasi R, Pagano A, Terzoli E, Amadori S (1999) Recombinant human granulocyte-macrophage colony-stimulating factor plus erythropoietin for the treatment of cytopenias in patients with myelodysplastic syndromes. Br J Haematol 105:141–148

    Article  PubMed  CAS  Google Scholar 

  • Suarez L, Vidriales MB, Sanz G, Lopez A, Lopez-Berges MC, de Santiago M, Palomera L, Bernal T, Perez dEM, San Miguel JF, Orfao A (2004) Expression of APO2.7, bcl-2 and bax apoptosis-associated proteins in CD34− bone marrow cell compartments from patients with myelodysplastic syndromes. Leukemia 18:1311–1313

    PubMed  CAS  Google Scholar 

  • Tehranchi R, Fadeel B, Forsblom AM, Christensson B, Samuelsson J, Zhivotovsky B, Hellstrom-Lindberg E (2003) Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors. Blood 101:1080–1086

    Article  PubMed  CAS  Google Scholar 

  • Terpos E, Mougiou A, Kouraklis A, Chatzivassili A, Michalis E, Giannakoulas N, Manioudaki E, Lazaridou A, Bakaloudi V, Protopappa M, Liapi D, Grouzi E, Parharidou A, Symeonidis A, Kokkini G, Laoutaris NP, Vaipoulos G, Anagnostopoulos NI, Christakis JI, Meletis J, Bourantas KL, Zoumbos NC, Yataganas X, Viniou NA, for The Greek MDS Study Group (2002) Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients. Br J Haematol 118:174–180

    Article  PubMed  CAS  Google Scholar 

  • Thompson JA, Gilliland DG, Prchal JT, Bennett JM, Larholt K, Nelson RA, Rose EH, Dugan MH (2000) Effect of recombinant human erythropoietin combined with granulocyte/macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome. Blood 95:1175–1179

    PubMed  CAS  Google Scholar 

  • Vadhan-Raj S, Keating M, LeMaistre A, Hittelman WN, McCredie K, Trujillo JM, Broxmeyer HE, Henney C, Gutterman JU (1987) Effects of recombinant human granulocyte macrophage colony stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 317:1545–1552

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ninewells Hospital & Medical School, Dundee, DD1 9SY, Scotland, UK

    David T. Bowen M.D.

Authors
  1. David T. Bowen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Bowen, D.T. (2006). Hematopoietic Growth Factors. In: Hematologic Malignancies: Myelodysplastic Syndromes. Hematologic Malignancies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30794-X_10

Download citation

  • DOI: https://doi.org/10.1007/3-540-30794-X_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-26188-9

  • Online ISBN: 978-3-540-30794-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation